You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Merosin Deficient

Showing 1 - 25 of 837
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Infants and Toddlers With LAMA2-CMD

Completed
  • Merosin Deficient Congenital Muscular Dystrophy
    • Lakewood, California
      Cure CMD, Inc.
    Jan 21, 2022

    Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy

    Recruiting
    • Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency
    • +51 more
      • Lakewood, California
        Congenital Muscle Disease International Registry (www.cmdir.org)
      Aug 3, 2021

      Spinal Muscular Atrophy, Merosin Deficient Congenital Muscular Dystrophy Trial in Copenhagen (Fasting)

      Completed
      • Spinal Muscular Atrophy
      • Merosin Deficient Congenital Muscular Dystrophy
      • Fasting
      • Copenhagen, Denmark
        Copenhagen Neuromuscular Center
      May 29, 2019

      SMA, DMD, BMD Trial in Switzerland

      Recruiting
      • SMA
      • +4 more
        • Bellinzona, Ticino, Switzerland
        • +14 more
        Nov 3, 2021

        Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications Trial in New York (Oral

        Not yet recruiting
        • Adolescent Idiopathic Scoliosis
        • +6 more
        • Oral ferrous sulfate
        • Oral placebo tablet
        • New York, New York
          Columbia University Medical Center
        Sep 12, 2023

        Guided Bone Regeneration Trial in Cairo (Double layer technique)

        Completed
        • Guided Bone Regeneration
        • Double layer technique
        • Cairo, Egypt
          Ain shams university , faculty of dentistry
        Nov 15, 2023

        Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Malignant Solid Neoplasm
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 31, 2022

        CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)

        Active, not recruiting
        • CD55-deficient Protein-losing Enteropathy
        • CHAPLE
        • Bethesda, Maryland
        • +2 more
        Nov 8, 2022

        Patients With Mutations in SEPN1 (SELENON) or LAMA2

        Recruiting
        • MDC1A
        • SELENON-related Myopathy
        • No intervention
        • Nijmegen, Gelderland, Netherlands
          Radboudumc
        Apr 27, 2022

        Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

        Not yet recruiting
        • Ovarian Cancer
        • Olaparib tablet
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Nov 1, 2023

        Dry Eye Trial in Gallarate (Rexon-Eye)

        Completed
        • Dry Eye
        • Rexon-Eye
        • Gallarate, VA, Italy
          Centro Oculistico Borroni
        Nov 3, 2023

        LAMA2-related Muscular Dystrophy Brain Study

        Withdrawn
        • LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
          • San Pedro, California
            CMDIR
          Mar 5, 2018

          Vitamin D Deficiency Trial in Jakarta Pusat (Cholecalciferol)

          Active, not recruiting
          • Vitamin D Deficiency
          • Jakarta Pusat, DKI Jakarta, Indonesia
            Cipto Mangunkusumo National Center General Hospital
          Sep 22, 2023

          Vitamin D Deficiency Trial in Jamshoro (Soft gelatin 200000 IU vitamin D3 capsule, Orodispersible (sachet) 200000 IU vitamin D3)

          Enrolling by invitation
          • Vitamin D Deficiency
          • Soft gelatin 200000 IU vitamin D3 capsule
          • Orodispersible (sachet) 200000 IU vitamin D3
          • Jamshoro, Sindh, Pakistan
            Liaquat Medical University Hospital
          Jan 20, 2023

          Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food Trial (luteine and zeaxanthine, luteine, zeaxanthine)

          Not yet recruiting
          • Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food
          • luteine and zeaxanthine
          • +3 more
          • (no location specified)
          Mar 20, 2023

          Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

          Recruiting
          • Prostate Cancer
          • talazoparib plus enzalutamide
          • Placebo plus enzalutamide
          • Birmingham, Alabama
          • +306 more
          Jan 18, 2023

          Osteoarthritis Trial in New York (Ensure)

          Recruiting
          • Osteoarthritis
          • Ensure
          • New York, New York
          • +1 more
          Oct 11, 2022

          Colon Cancer Trial (Pembrolizumab)

          Not yet recruiting
          • Colon Cancer
          • (no location specified)
          Dec 14, 2022

          Vitamin D Deficiency, Vitamin D Insufficiency Trial in Boston (UVB treatment)

          Completed
          Has Results
          • Vitamin D Deficiency
          • Vitamin D Insufficiency
          • UVB treatment
          • Boston, Massachusetts
            General Clinical Research Unit (GCRU) BU School of Medicine
          Dec 2, 2022

          CD55-Deficient Protein-Losing Enteropathy Trial (Pozelimab)

          Available
          • CD55-Deficient Protein-Losing Enteropathy
          • (no location specified)
          Aug 14, 2023

          Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in

          Recruiting
          • Recurrent Endometrial Adenocarcinoma
          • +8 more
          • Ipilimumab
          • Nivolumab
          • Iowa City, Iowa
          • +9 more
          Jan 27, 2023

          Endometrial Cancer Trial in France (Carboplatin-Paclitaxel, Dostarlimab)

          Recruiting
          • Endometrial Cancer
          • Angers, France
          • +40 more
          Aug 9, 2022

          Metastatic Colorectal Cancer Trial in China (HX008, Investigator's Choice Chemotherapy)

          Not yet recruiting
          • Metastatic Colorectal Cancer
          • HX008
          • Investigator's Choice Chemotherapy
          • Hefei, Anhui, China
          • +9 more
          Dec 8, 2022

          Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

          Active, not recruiting
          • Advanced Colorectal Carcinoma
          • +24 more
          • Houston, Texas
            M D Anderson Cancer Center
          Oct 20, 2022

          Treatment in FH-deficient RCC Patients

          Recruiting
          • FH-Deficient RCC
          • +2 more
          • Laboratory analysis of samples
          • Shanghai, Shanghai, China
            Ethics Committee of Shanghai Renji Hospital
          Sep 6, 2022